glp 1 announcement A Medicare pilot program aimed at expanding access to GLP-1 weight-loss medications has been delayed until at least 2027, according to a recent announcement. Learn more at the link in our bio. # GLP-1 medications get at the
Description
[DOI] [PubMed] [Google Scholar] 55.Tripathy NR, Basha S, Jain R, Shetty S, Ramachandran A
34 found that liraglutide ( n = 55) significantly decreased fat mass and waist-to-hip ratio (WHR), with reductions of 3.1 kg in fat mass and 0.08 in WHR
Clinical Nutrition , 38(6), 2645-2651
If switching is not possible or not preferred, a pragmatic approach involves increasing oral progesterone from 100 mg to 200 mg daily for the first 4-6 weeks of semaglutide treatment
This is the 2026 update competitor content keeps missing
